Pharmed (0543.397.364): annual accounts, directors and company register

Pharmed

Schaerbeek ·KBO/BCE: BE 0543.397.364

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Group	Expected	Actual
1	0.2%	0.2%
2	0.3%	0.5%
3	0.5%	0.6%
4	0.7%	0.8%
5	0.9%	0.9%
6	1.3%	1.5%
7	1.6%	1.8%
8	1.8%	1.8%
9	3.0%	3.1%
10	5.6%	6.2%

Company
Pharmed Schaerbeek	€183,800	€71,199	24.4%	-
LE LUMEÇON Brussels	€213,394	€57,375	51.8%	0
PHARMACIE DU PETIT RY Ciney	€186,402	€62,395	96.9%	-
PHARMACIE SWINNEN Liège	€214,057	€64,010	65.1%	0.7
Ilse Verstraeten Sint-Truiden	€178,548	€74,847	97.9%	-
GILSON MARIE-CLAIRE Vaux-sur-Sûre	€221,736	€68,923	87.0%	-
LYNAPHARMA Sint-Gillis (bij-Brussel)	€177,178	€60,362	82.7%	-

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Balance sheet: assets
`20/58`	183,800	198,001	184,376	208,489	218,030	221,666	267,123	289,928	294,334	299,863	300,977	258,708
`21/28`	35,016	25,242	25,978	35,145	50,347	54,131	69,044	76,258	89,910	95,646	114,947	119,585
`21`	-	-	-	10,542	22,042	33,542	45,042	56,542	68,042	79,542	91,042	102,542
`22/27`	34,856	25,082	25,818	24,444	28,146	20,429	23,843	19,556	21,708	15,979	23,780	17,003
`23`	26,217	17,227	15,448	19,162	22,895	20,429	23,562	18,995	13,358	1,591	1,821	2,051
`24`	8,639	7,856	10,370	5,282	5,251	-	281	561	8,350	14,389	21,959	14,952
`28`	160	160	160	160	160	160	160	160	160	125	125	40
`29/58`	148,784	172,758	158,399	173,343	167,683	167,535	198,079	213,670	204,425	204,217	186,030	139,123
`3`	63,072	86,437	74,485	73,084	65,240	63,063	63,871	56,599	54,680	47,714	38,713	36,094
`30/36`	63,072	86,437	74,485	73,084	65,240	63,063	63,871	56,599	54,680	47,714	38,713	36,094
`40/41`	70,550	52,952	63,993	61,453	61,964	65,899	71,527	100,837	69,764	63,413	69,829	48,106
`40`	67,008	52,827	63,978	50,453	58,587	58,929	58,923	81,970	51,049	61,531	68,186	47,803
`41`	3,542	125	15	11,000	3,377	6,970	12,604	18,868	18,715	1,882	1,643	303
`54/58`	14,394	33,369	17,943	37,136	40,479	37,649	60,872	55,321	76,119	89,582	77,480	54,195
`490/1`	768	0	1,978	1,670	-	924	1,808	912	3,862	3,509	8	728
Balance sheet: equity and liabilities
`10/49`	183,800	198,001	184,376	208,489	218,030	221,666	267,123	289,928	294,334	299,863	300,977	258,708
`10/15`	44,788	43,766	8,055	8,055	8,055	8,055	8,055	8,404	8,969	15,710	17,003	8,442
`10/11`	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200
`100`	-	-	-	-	-	-	18,550	18,550	18,550	18,550	18,550	18,550
`101`	-	-	-	-	-	-	12,350	12,350	12,350	12,350	12,350	12,350
`13`	1,855	1,855	1,855	1,855	1,855	1,855	1,855	1,855	1,855	1,855	1,855	1,855
`130/1`	-	-	-	1,855	1,855	1,855	-	-	-	-	-	-
`130`	-	-	-	-	-	-	1,855	1,855	1,855	1,855	1,855	1,855
`1311`	-	-	-	1,855	1,855	1,855	-	-	-	-	-	-
`133`	1,855	1,855	1,855	-	-	-	-	-	-	-	-	-
`14`	36,733	35,711	-	-	-	-	-	349	914	7,655	8,948	387
`17/49`	139,013	154,234	176,321	200,434	209,975	213,611	259,068	281,524	285,365	284,153	283,974	250,266
`17`	-	-	-	10,536	28,124	45,134	61,584	77,493	92,879	107,759	122,149	136,065
`170/4`	-	-	-	10,536	28,124	45,134	61,584	77,493	92,879	107,759	122,149	136,065
`42/48`	139,013	154,234	176,288	189,816	181,721	166,955	195,962	202,508	190,964	174,858	160,859	113,777
`42`	-	0	12,024	19,028	18,402	16,450	15,909	15,386	14,879	14,390	13,917	14,560
`44`	102,131	88,878	92,510	98,049	112,699	101,746	111,864	130,151	120,656	114,443	122,182	80,836
`440/4`	102,131	88,878	92,510	98,049	112,699	101,746	111,864	130,151	120,656	114,443	122,182	80,836
`45`	33,253	41,623	39,102	35,627	26,509	28,956	33,285	31,972	31,629	24,025	14,760	7,681
`450/3`	19,896	27,848	25,032	26,574	16,756	19,587	20,489	26,076	28,000	24,025	10,938	7,681
`454/9`	13,357	13,775	14,070	9,053	9,753	9,369	12,796	5,896	3,629	-	3,823	-
`47/48`	3,629	23,733	32,652	37,112	24,111	19,802	34,904	25,000	23,800	22,000	10,000	10,700
`492/3`	-	0	34	83	130	1,522	1,522	1,522	1,522	1,536	967	424
Income statement
`9900`	71,199	130,261	127,314	139,484	115,471	119,852	126,300	94,420	88,653	57,836	60,987	45,877
`62`	57,289	54,483	67,651	69,836	64,003	73,860	60,843	39,241	20,727	190	5,671	-
`630`	9,146	9,287	18,559	17,695	15,654	14,914	14,914	16,894	19,102	19,300	19,439	18,884
`640/8`	410	139	58	500	81	245	1,223	1,112	558	761	1,449	787
`9901`	4,354	66,352	41,046	51,453	35,732	30,833	49,321	37,174	48,266	37,584	34,428	26,206
`75/76B`	4	7	22	73	20	6	1	31	4	4	78	51
`75`	4	7	22	73	20	6	1	31	4	4	78	51
`65/66B`	1,326	2,480	2,542	2,095	2,891	3,595	4,187	4,085	4,074	4,693	4,997	6,371
`65`	1,326	2,480	2,542	2,095	2,891	3,595	4,187	4,085	4,074	4,693	4,997	6,371
`9903`	3,032	63,880	38,526	49,431	32,862	27,244	45,135	33,119	44,196	32,895	29,509	19,886
`67/77`	2,011	16,169	10,672	12,320	8,750	7,441	10,579	8,685	16,937	12,188	10,948	6,944
`9904`	1,022	47,711	27,853	37,112	24,111	19,802	34,556	24,435	27,259	20,707	18,561	12,942
`9905`	1,022	47,711	27,853	37,112	24,111	19,802	34,556	24,435	27,259	20,707	18,561	12,942
Appropriation of the result
`9906`	36,733	47,711	27,853	37,112	24,111	19,802	34,904	25,349	34,914	29,655	18,948	12,942
`14P`	35,711	-	-	-	-	-	-	-	-	-	-	-
`691/2`	-	-	-	-	-	-	-	-	-	-	-	1,855
`6920`	-	-	-	-	-	-	-	-	-	-	-	1,855
`694/7`	0	12,000	27,853	37,112	24,111	19,802	34,904	25,000	34,000	22,000	10,000	10,700
`694`	0	12,000	27,853	37,112	24,111	19,802	34,904	25,000	34,000	22,000	10,000	10,700
Social balance sheet
`9087`	1	1.5	1.6	1.4	1.4	1.4	1	0.7	0.6	-	0.1	-
Hours worked`1013`	1,714	1,795	2,555	2,351	2,674	2,561	1,762	1,118	1,094	-	305	-
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	micro format	27-08-2026	2026-00433162	PDF
31-12-2024	micro format	11-08-2025	2025-00368498	PDF
31-12-2023	micro format	21-08-2024	2024-00355872	PDF
31-12-2022	micro format	09-08-2023	2023-00320668	PDF
31-12-2021	micro format	13-07-2022	2022-20179481	PDF
31-12-2020	micro format	31-08-2021	2021-65200264	PDF
31-12-2019	micro format	01-09-2020	2020-49800342	PDF
31-12-2018	micro format	02-08-2019	2019-44400451	PDF
31-12-2017	micro format	31-08-2018	2018-60800165	PDF
31-12-2016	micro format	29-08-2017	2017-51500125	PDF
31-12-2015	full format	25-08-2016	2016-48400419	PDF
31-12-2014	full format	10-08-2015	2015-41200103	PDF

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
13,500	75,639	59,605	69,148	51,387	45,747	64,235	54,068	67,368	56,884	53,868	45,090
10,168	56,998	46,412	54,807	39,765	34,716	49,469	41,329	46,361	40,008	38,000	31,826
18,920	8,551	9,392	2,493	11,871	0	7,700	8,842	13,365	0	14,801	137,352
-18,974	15,426	-19,193	-3,343	2,830	-23,224	5,551	-20,798	-13,463	12,102	23,285	-
9,772	18,524	-17,889	-16,472	-14,038	580	2,117	11,161	13,461	29,359	25,171	25,346
24.4%	22.1%	4.4%	3.9%	3.7%	3.6%	3.0%	2.9%	3.0%	5.2%	5.6%	3.3%
1.07	1.12	0.90	0.91	0.92	1.00	1.01	1.06	1.07	1.17	1.16	1.22
0.62	0.56	0.48	0.53	0.56	0.63	0.68	0.78	0.78	0.90	0.92	0.91
3.10	3.52	21.89	24.88	26.07	26.52	32.16	33.50	31.82	18.09	16.70	29.65
2.3%	109.0%	345.8%	460.7%	299.3%	245.8%	429.0%	290.8%	303.9%	131.8%	109.2%	153.3%
0.6%	24.1%	15.1%	17.8%	11.1%	8.9%	12.9%	8.4%	9.3%	6.9%	6.2%	5.0%
10.18	30.50	23.45	33.01	17.77	-	-	-	-	-	-	-

Item	31-12-2025	31-12-2024	31-12-2023	31-12-2022	31-12-2021
Employees at the balance-sheet date	1	1	2	2	2
full-time	0	0	-	1	1
part-time	1	1	2	1	1
in full-time equivalents	0.8	0.8	1.4	1.6	1.5
	1	1.1	1.3	1.4	1.4
On a permanent contract	1	1	1	1	2
Joined	1	0	1	1	-
Left	1	1	1	1	-

Item	2025	2024	2023	2022	2021
Tangible fixed assets	€18,920	€8,551	€9,392	€2,493	€11,871
Financial fixed assets	€0	-	-	-	-
	€9,146	€9,287	€18,559	€17,695	€15,654

Overview

Lifetime

Key points

Equity

Turnover

Debts

Investments

Staff

Filings

Checked score

Score breakdown

Comparable companies, two years later

Credit verdict

Signals

Board and ownership

Recent changes

Comparable companies

Official details

Annual accounts 2025

Insights on Pharmed

Financials

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency24.4%

Current ratio1.07

Return on assets0.6%

Staff

Staff cost per FTE€57,289

Joined and leftlevel

Filed annual accounts

Filings

Key figures and ratios

Social balance sheet

Investments

Insights on Pharmed

Board & ownership

Board

Mandates through the years

Control

Capital

Network & group

No group

Timeline

Timeline

History

Company details

Identity

Activities

Registered office and establishments

Buildings and parcels at the address

Location

Parcels

in euro

in euro

24.4%

1.07

0.6%

€57,289

level